FEG
TMO icon

Financial Enhancement Group’s Thermo Fisher Scientific TMO Stock Holding History

Financial Enhancement Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-85
Closed -$43K – 301
2022
Q3 		$43K Hold
85
– – 0.01% 144
2022
Q2 		$46K Hold
85
– – 0.01% 139
2022
Q1 		$50K Hold
85
– – 0.01% 135
2021
Q4 		$57K Hold
85
– – 0.01% 134
2021
Q3 		$49K Hold
85
– – 0.01% 135
2021
Q2 		$43K Hold
85
– – 0.01% 133
2021
Q1 		$39K Sell
85
-15
-15% -$7.16K 0.01% 131
2020
Q4 		$47K Hold
100
– – 0.01% 140
2020
Q3 		$44K Hold
100
– – 0.01% 128
2020
Q2 		$36K Buy
+100
New +$33.5K 0.01% 135

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Enhancement Group's TMO Position: Q4 2022 in Review

Financial Enhancement Group sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 85 shares — an estimated $43K sold.

Financial Enhancement Group first reported a position in TMO in Q2 2020 and held it in 10 quarters. The position peaked at $57K in Q4 2021. 2,375 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Financial Enhancement Group reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 85 Thermo Fisher Scientific shares in Q4 2022, an estimated $43K.
  • Financial Enhancement Group first reported a position in Thermo Fisher Scientific in Q2 2020 and held it in 10 quarters.
  • Financial Enhancement Group's Thermo Fisher Scientific position peaked at $57K in Q4 2021.
  • 2,375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.